Ameriprise Financial Inc Altimmune, Inc. Transaction History
Ameriprise Financial Inc
- $356 Billion
- Q1 2025
A detailed history of Ameriprise Financial Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,443,932 shares of ALT stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,443,932
Previous 5,254,898
72.52%
Holding current value
$10.3 Million
Previous $37.9 Million
80.95%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ALT
# of Institutions
203Shares Held
37.6MCall Options Held
2MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$31.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$24.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$19.6 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$12.2 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $350M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...